e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation III
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis
M. Lapa, M. Acencio, A. Farias, C. Fernandes, C. Jardim, R. Souza, M. Terra-Filho (Brazil)
Source:
Annual Congress 2010 - Pulmonary circulation III
Session:
Pulmonary circulation III
Session type:
Thematic Poster Session
Number:
1146
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lapa, M. Acencio, A. Farias, C. Fernandes, C. Jardim, R. Souza, M. Terra-Filho (Brazil). P-selectin and PDGF serum levels might not be related to idiopathic pulmonary arterial hypertension and schistosomiasis. Eur Respir J 2010; 36: Suppl. 54, 1146
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Circulating angiopoietins in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
The role of fractalkine in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Serum levels of vascular endothelial growth factor in patients with systemic sclerosis. Correlation with systolic pressure in the pulmonary artery
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
The interleukin 13 receptor system is altered in pulmonary arterial hypertension
Source: Annual Congress 2006 - Lung vascular and parenchymal remodeling
Year: 2006
Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Possible role of imatinib in clinical pulmonary veno-occlusive disease
Source: Eur Respir J 2008; 32: 232-235
Year: 2008
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012
Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012
Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension},
Source: Eur Respir J 2012; 40: 895-904
Year: 2012
Treatment of early systemic sclerosis associated pulmonary arterial hypertension with endothelin receptor antagonists improves survival
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept